BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 16054753)

  • 41. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
    Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
    Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.
    Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M
    Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
    Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
    Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
    Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
    Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population.
    Wu X; Jiang S; Lin S; Tang G; Feng G; Qian Y; Wang D; Ren D; Gu N
    Am J Med Genet; 1999 Feb; 88(1):1-3. PubMed ID: 10050959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
    Fenoglio C; Galimberti D; Lovati C; Guidi I; Gatti A; Fogliarino S; Tiriticco M; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
    Neurobiol Aging; 2004 Oct; 25(9):1169-73. PubMed ID: 15312962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease.
    Kishikawa S; Li JL; Gillis T; Hakky MM; Warby S; Hayden M; MacDonald ME; Myers RH; Gusella JF
    Neurobiol Dis; 2006 Nov; 24(2):280-5. PubMed ID: 16962786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.
    Grünblatt E; Zehetmayer S; Bartl J; Löffler C; Wichart I; Rainer MK; Jungwirth S; Bauer P; Danielczyk W; Tragl KH; Riederer P; Fischer P
    J Psychiatr Res; 2009 Jan; 43(3):298-308. PubMed ID: 18603262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan.
    Akatsu H; Yamagata HD; Kawamata J; Kamino K; Takeda M; Yamamoto T; Miki T; Tooyama I; Shimohama S; Kosaka K
    Dement Geriatr Cogn Disord; 2006; 22(3):216-22. PubMed ID: 16899999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain-derived neurotrophic factor gene polymorphisms and serum levels in Chinese atopic dermatitis patients.
    Ma L; Gao XH; Zhao LP; Di ZH; Mchepange UO; Zhang L; Chen HD; Wei HC
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1277-81. PubMed ID: 19522715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
    Pola R; Flex A; Gaetani E; Proia AS; Papaleo P; Di Giorgio A; Straface G; Pecorini G; Serricchio M; Pola P
    Exp Gerontol; 2004 Aug; 39(8):1249-52. PubMed ID: 15288699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Guarnieri BM; Bartoli A; Serio A; Piacentini S; Sorbi S
    Neurosci Lett; 2006 Jan; 392(1-2):110-3. PubMed ID: 16188386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
    Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
    Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome.
    Zubenko GS; Stiffler JS; Hughes HB; Hurtt MR; Kaplan BB
    Am J Med Genet; 1998 Mar; 81(2):196-205. PubMed ID: 9613863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis.
    Ikram MA; Liu F; Oostra BA; Hofman A; van Duijn CM; Breteler MM
    Biol Psychiatry; 2009 Jun; 65(11):995-9. PubMed ID: 19118819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
    Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
    Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.